×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: US | Boston | Scientific | Suspension

Analyst: Boston Scientific Suspends Device Sales

Monday, 15 March 2010 09:34 AM

An analyst says Boston Scientific has suspended all sales of its implantable cardioverter defibrillators after finding a documentation error in regulatory filings.

Bernstein senior analyst Derrick Sung says in a research note the error puts the Natick, Mass., medical device maker's devices out of compliance with Food and Drug Administration regulations. He also says the error is tied to documentation. It does not appear to be tied to quality or safety concerns.

Boston Scientific spokesman Paul Donovan could not be immediately reached for comment.

The devices shock the heart to restore a regular rhythm. Sung says their sales make up 15 percent of total company revenue.

© Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Markets
An analyst says Boston Scientific has suspended all sales of its implantable cardioverter defibrillators after finding a documentation error in regulatory filings.Bernstein senior analyst Derrick Sung says in a research note the error puts the Natick, Mass., medical device...
US,Boston,Scientific,Suspension
106
2010-34-15
Monday, 15 March 2010 09:34 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved